These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27288239)

  • 1. Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
    Sansevero G; Begenisic T; Mainardi M; Sale A
    Exp Neurol; 2016 Sep; 283(Pt A):49-56. PubMed ID: 27288239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal and brain region-specific elevations of soluble Amyloid-β
    Tallino S; Winslow W; Bartholomew SK; Velazquez R
    Aging Cell; 2022 Apr; 21(4):e13590. PubMed ID: 35290711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.
    Belichenko PV; Madani R; Rey-Bellet L; Pihlgren M; Becker A; Plassard A; Vuillermot S; Giriens V; Nosheny RL; Kleschevnikov AM; Valletta JS; Bengtsson SK; Linke GR; Maloney MT; Hickman DT; Reis P; Granet A; Mlaki D; Lopez-Deber MP; Do L; Singhal N; Masliah E; Pearn ML; Pfeifer A; Muhs A; Mobley WC
    PLoS One; 2016; 11(3):e0152471. PubMed ID: 27023444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
    Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
    Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.
    Illouz T; Madar R; Biragyn A; Okun E
    Brain Behav Immun; 2019 Jan; 75():163-180. PubMed ID: 30389461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer receptors enhance memory in a mouse model of Down syndrome.
    Fortress AM; Hamlett ED; Vazey EM; Aston-Jones G; Cass WA; Boger HA; Granholm AC
    J Neurosci; 2015 Jan; 35(4):1343-53. PubMed ID: 25632113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
    Hunter CL; Bimonte-Nelson HA; Nelson M; Eckman CB; Granholm AC
    Neurobiol Aging; 2004 Aug; 25(7):873-84. PubMed ID: 15212841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
    Kazim SF; Blanchard J; Bianchi R; Iqbal K
    Sci Rep; 2017 Apr; 7():45561. PubMed ID: 28368015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early environmental therapy rescues brain development in a mouse model of Down syndrome.
    Begenisic T; Sansevero G; Baroncelli L; Cioni G; Sale A
    Neurobiol Dis; 2015 Oct; 82():409-419. PubMed ID: 26244989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
    Begenisic T; Baroncelli L; Sansevero G; Milanese M; Bonifacino T; Bonanno G; Cioni G; Maffei L; Sale A
    Neurobiol Dis; 2014 Mar; 63():12-9. PubMed ID: 24269730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
    Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
    Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
    Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
    J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.
    Hüttenrauch M; Walter S; Kaufmann M; Weggen S; Wirths O
    Mol Neurobiol; 2017 Oct; 54(8):6542-6555. PubMed ID: 27734334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.
    Stringer M; Abeysekera I; Dria KJ; Roper RJ; Goodlett CR
    Pharmacol Biochem Behav; 2015 Nov; 138():70-9. PubMed ID: 26363314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.